AB 669 (Haney, D-San Francisco)

AB 669 would prohibit health plans, starting in 2027, from concurrent or retrospective review of medical necessity of in-network services and benefits for the first 28 days of residential, inpatient, partial hospitalization, or intensive outpatient therapy for substance use treatment. The bill specifies a concurrent or retrospective review with an appeal process for intensive outpatient or partial hospitalization services for substance use disorder treatment that lasts longer than 28 days.

Senate Health Committee Support Letter

Senate Appropriations Committee Support Letter